language_icon
EN
HI

Beta Drugs Share price

BETA

1106.1

36.40 (3.40%)
Last updated on 20 Mar, 2026 | 15:31 IST
Today's High

1135.60

Today's Low

1080.00

52 Week Low

990.10

52 Week High

2000.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Beta Drugs Chart

Beta Drugs Share Key Metrics

Volume
18428.00
Market Cap
1116.56 CR
LTQ@LTP
1@1106.10
ATP
1114.53
Var Margin
15.23 %
Circuit Range
855.8-1283.6
Delivery %
65.72 %
Value
2.05 CR
ASM/GSM
No
Market Lot
1

Summary

At 20 Mar, 2026 | 15:31, Beta Drugs share price stands at ₹1106.1, showing a 36.40% 3.40 for the day. The stock’s intraday movement has stayed between ₹1080.00 and ₹1135.60, while on a 52-week basis it has fluctuated from ₹990.10 to ₹2000.00.
In terms of trading activity, Beta Drugs has recorded a volume of 18428 shares, with a market capitalisation of ₹10094553. The stock’s Average Traded Price (ATP) stands at ₹111453, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1,110610. The stock operates within a circuit range of ₹855.8-1283.6, with a Value of ₹2.05 CR. The Delivery Percentage for the day is 65.72%. Additionally, Beta Drugs currently falls under the No framework, and trades with a market lot size of 1.

Beta Drugs Fundamentals

View More
P/E Ratio

26.51

P/B Ratio

5.47

Div. Yield

0

Sector P/E

60.47

Sector P/B

2.66

Sec. Div. Yield

0.59

Beta Drugs Resistance and Support

Pivot 1082.47

Resistance

First Resistance

1102.24

Second Resistance

1134.77

Third Resistance

1154.54

Support

First Support

1049.94

Second Support

1030.17

Third Support

997.64

Beta Drugs Futures & Options

Data Not Found

Beta Drugs Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

64.9%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

1.14%

Domestic Institutional Investors

1.88%

Retail

32.08%

Others

0%

Total Promoters
MAR '25
66.73%
JUN '25
66.73%
SEP '25
66.73%
DEC '25
64.9%

Beta Drugs Corporate Actions

DateAgenda
2026-02-14Quarterly Results
2026-01-09Others

Beta Drugs News

Beta Drugs Limited (BETA)

Beta Drugs clarifies the percentage of post-preferential offer capital for allottees. This clarification addresses observations from the National Stock Exchange regarding a prior EGM notice.
Mar 20 2026 10:03:00

Beta Drugs Limited (BETA)

Beta Drugs clarified its shareholding pattern changes in response to NSE observations concerning a proposed preferential issue of equity shares. Post-issue, promoter holding is projected to be 59.10%, down from 64.90%, while institutional investors' stake will increase significantly to 9.14%.
Mar 16 2026 16:03:00
Read More

About Beta Drugs

NSE : 759842  
BSE : 0  
ISIN : INE351Y01019  

The Company was incorporated as ?Beta Drugs Private limited? at Himachal Pradesh as a private limited company under the provisions of the Companies Act 1956 vide Certificate of Incorporation dated September 21 2005 bearing Corporate Identification Number U24230HP2005PTC28969 issued by Registrar of Companies Punjab Himachal Pradesh and Chandigarh. Subsequently the Company was converted in to public limited company pursuant to Shareholders Resolution passed at the Extra-Ordinary General Meeting of the Company held on July 24 2017 and the name of the Company was changed to ?Beta Drugs Limited? pursuant to issuance of fresh Certificate of Incorporation consequent upon conversion of Company from Private to Public Limited dated August 11 2017 issued by the Registrar of Companies Himachal Pradesh. The Corporate Identification Number of the Company is U24230HP2005PLC028969.KEY EVENTS AND MILESTONES IN THE HISTORY OF THE COMPANY2005 -Incorporation of the Company as Beta Drugs Private Limited2014 -Vijay Kumar Batra existing promoter took over the Company2015-ISO: 9001:2008 Certification for manufacturing and supply of Pharmaceutical products such as Oncology  Sterile Injections and Lyophilized Injections and Oncology solid oral medication tablets and capsules-Certificate of Good Manufacturing Practice from Health and Family Welfare Department Himachal Pradesh2016-Certificate of Good Manufacturing Practice from Republic of Kenya2017 -Conversion of Company into Public Limited Company

Read More

Beta Drugs Management

NamePosition
Mr. Rahul Batra Chairperson & Managing Director
Mr. Varun Batra Joint Managing Director
View More

Beta Drugs FAQs

The Buying Price of Beta Drugs share is 1106.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Beta Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Beta Drugs, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Beta Drugs shares is 26.51. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Beta Drugs shares is 5.47. Useful to assess the stock's value relative to its book value.

To assess Beta Drugs’s valuation compare Sector P/E, P/B which are 60.47 & 2.66 with sector averages, along with growth rates and financial metrics.

The Market Cap of Beta Drugs is 1116.56 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Beta Drugs share price is 2000.00 & 990.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Beta Drugs belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost